$81.61
-0.88 (-1.07%)
At Close: Jun 24, 2026
Zacks Industry Outlook Intercontinental Exchange, CME, Nasdaq, Cboe Global Markets
03:14am, Wednesday, 05'th Mar 2025
Intercontinental Exchange, CME, Nasdaq, Cboe Global Markets have been highlighted in this Industry Outlook article.
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:00pm, Tuesday, 04'th Mar 2025
BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies fo
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Tuesday, 04'th Mar 2025
SAN FRANCISCO, March 04, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:10pm, Tuesday, 04'th Mar 2025
BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:07pm, Tuesday, 04'th Mar 2025
CHARLESTOWN, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and
Sanuwave Health to Uplist to the Nasdaq Global Market
04:06pm, Tuesday, 04'th Mar 2025
Trading Under the Ticker “SNWV” Expected to Begin on March 7, 2025 Trading Under the Ticker “SNWV” Expected to Begin on March 7, 2025
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Tuesday, 04'th Mar 2025
CAMBRIDGE, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease
Nasdaq Reports February 2025 Volumes
04:05pm, Tuesday, 04'th Mar 2025
NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for February 2025 on its Investor Relations website. A data sheet showing this information can be foun
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Tuesday, 04'th Mar 2025
FRAMINGHAM, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring o
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Tuesday, 04'th Mar 2025
SAN DIEGO, March 04, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Tuesday, 04'th Mar 2025
CAMBRIDGE, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based ther
Diginex Limited to Ring the Nasdaq Closing Bell on March 5, 2025
04:00pm, Tuesday, 04'th Mar 2025
LONDON, March 04, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex Limited” or the “Company”) (Nasdaq: DGNX), an impact technology company specializing in environmental, social, and governan
NKGen Biotech, Inc. to Transition from the Nasdaq Global Market to OTC Markets; Reverse Stock Split will not be Implemented
01:00pm, Tuesday, 04'th Mar 2025
SANTA ANA, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologo
4 Securities and Exchanges Stocks to Watch With Increased Volatility
12:05pm, Tuesday, 04'th Mar 2025
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, NDAQ and CBOE. However, compliance with regulat
S&P 500 And Nasdaq Hit 2025 Lows As Trump's Tariffs Take Effect—Tesla Stock Leads Losers
10:12am, Tuesday, 04'th Mar 2025
Stocks dropped again Tuesday as President Donald Trump's tariffs sparked queasiness on Wall Street, and leading the stock market woes were shares of Tesla, the electric vehicle firm run by Trump's top
Sign In
Buy NDAQ